Daphne C Rohrich1, Eline H M van de Wetering2, Alexander J Rennings3, Elke E Arts2, Inger L Meek2, Alfons A den Broeder1, Jaap Fransen2, Calin D Popa4,5. 1. Department of Rheumatology, Sint Maartenskliniek, Hengstdal nr. 3, 6574 NA, Ubbergen, The Netherlands. 2. Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB, Nijmegen, The Netherlands. 3. Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB, Nijmegen, The Netherlands. 4. Department of Rheumatology, Sint Maartenskliniek, Hengstdal nr. 3, 6574 NA, Ubbergen, The Netherlands. c.popa@maartenskliniek.nl. 5. Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB, Nijmegen, The Netherlands. c.popa@maartenskliniek.nl.
Abstract
BACKGROUND: Rheumatoid arthritis (RA) patients have an increased cardiovascular (CV) risk. Here, we aimed to investigate whether gender and age are contributing to the misclassification of CV risk in RA patients. METHODS: Prospectively collected data on cardiovascular risk factors and incident events from the Nijmegen inception cohort were analyzed, with up to 10 years follow-up. Original as well as the EULAR-modified (M)_SCORE algorithms were used to calculate CV risk. Patients were stratified in deciles according to predicted risk; the Hosmer-Lemeshow test was used to check concordance between observed and predicted risk, in subgroups of gender and age. RESULTS: There were 863 RA patients included with 128 incident CV events. When using SCORE in the whole group, there was evidence of a discrepancy between the predicted and observed CV risk (H-L test p < 0.003), mainly present in the female subgroup (H-L test p < 0.001). Interestingly, 36% of females who developed an event belonged to the low CV risk group, whereas this was just 10% in RA males. When analyzing the subgroups based on age, a discrepancy was present only in the youngest patients (H-L test p < 0.001 in patients < 55 years) consisting of an underestimation of CV risk (5.3% predicted vs. 8.0% observed). Similar results were obtained when the M_SCORE was applied. CONCLUSION: CV risk is especially underestimated in female and younger RA patients. This suggests that modifying the weight for the female gender and/or younger age in currently used CV risk algorithms might improve their predictive value in RA, contributing to better CV risk management.
BACKGROUND:Rheumatoid arthritis (RA) patients have an increased cardiovascular (CV) risk. Here, we aimed to investigate whether gender and age are contributing to the misclassification of CV risk in RApatients. METHODS: Prospectively collected data on cardiovascular risk factors and incident events from the Nijmegen inception cohort were analyzed, with up to 10 years follow-up. Original as well as the EULAR-modified (M)_SCORE algorithms were used to calculate CV risk. Patients were stratified in deciles according to predicted risk; the Hosmer-Lemeshow test was used to check concordance between observed and predicted risk, in subgroups of gender and age. RESULTS: There were 863 RApatients included with 128 incident CV events. When using SCORE in the whole group, there was evidence of a discrepancy between the predicted and observed CV risk (H-L test p < 0.003), mainly present in the female subgroup (H-L test p < 0.001). Interestingly, 36% of females who developed an event belonged to the low CV risk group, whereas this was just 10% in RA males. When analyzing the subgroups based on age, a discrepancy was present only in the youngest patients (H-L test p < 0.001 in patients < 55 years) consisting of an underestimation of CV risk (5.3% predicted vs. 8.0% observed). Similar results were obtained when the M_SCORE was applied. CONCLUSION: CV risk is especially underestimated in female and younger RApatients. This suggests that modifying the weight for the female gender and/or younger age in currently used CV risk algorithms might improve their predictive value in RA, contributing to better CV risk management.
Authors: M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed Journal: Ann Rheum Dis Date: 2009-09-22 Impact factor: 19.103
Authors: Cynthia S Crowson; Sherine E Gabriel; Anne Grete Semb; Piet L C M van Riel; George Karpouzas; Patrick H Dessein; Carol Hitchon; Virginia Pascual-Ramos; George D Kitas Journal: Rheumatology (Oxford) Date: 2017-07-01 Impact factor: 7.580
Authors: E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen Journal: Ann Rheum Dis Date: 2014-01-03 Impact factor: 19.103
Authors: Alfonso Corrales; José A Parra; Carlos González-Juanatey; Javier Rueda-Gotor; Ricardo Blanco; Javier Llorca; Miguel A González-Gay Journal: Ann Rheum Dis Date: 2013-07-13 Impact factor: 19.103
Authors: Emily C Pfeifer; Cynthia S Crowson; Shreyasee Amin; Sherine E Gabriel; Eric L Matteson Journal: J Rheumatol Date: 2014-06-01 Impact factor: 4.666
Authors: Alfonso Corrales; Patrick H Dessein; Linda Tsang; Trinitario Pina; Ricardo Blanco; Carlos Gonzalez-Juanatey; Javier Llorca; Miguel A Gonzalez-Gay Journal: Arthritis Res Ther Date: 2015-03-11 Impact factor: 5.156
Authors: Cynthia S Crowson; Silvia Rollefstad; George D Kitas; Piet L C M van Riel; Sherine E Gabriel; Anne Grete Semb Journal: PLoS One Date: 2017-03-23 Impact factor: 3.240